Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for constructing azoospermia mouse model

A construction method and technology of azoospermia, applied in the field of construction of azoospermia mouse model, can solve the problems of poor stability, low molding rate, high mortality rate, etc., and achieve the effect of good stability and high molding rate

Active Publication Date: 2018-11-16
THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV +1
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the existing methods are different, they all have the characteristics of low molding rate, poor stability and high mortality rate.
The lack of high modeling rate and good stability construction scheme seriously restricts the research progress of non-obstructive azoospermia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for constructing azoospermia mouse model
  • Method for constructing azoospermia mouse model
  • Method for constructing azoospermia mouse model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] A kind of embodiment of the construction method of azoospermia mouse model of the present invention, comprises the steps:

[0035] (1) C57BL / 6 male mice, which are sexually mature at 8-12 weeks, are used as model animals, with a body weight of 25-30g and no more than 35g; the modeling dose (busulfan) is 40mg / kg, and the cycle is 36 days;

[0036] (2) Taking a mouse with a body weight of 25g as an example, 1mg of busulfan is needed, dissolved in 0.05ml DMSO, prepared for immediate use, diluted to 2ml with normal saline (the ratio of DMSO to the total liquid volume is 2.5%), and transported on ice to animal center;

[0037] (3) After the mice enter the animal center after routine disinfection, shake the diluent well, draw 0.5ml diluent with an insulin needle (refer to Table 1 for details), disinfect the lower abdomen with alcohol, insert the needle after it is slightly dry, and draw back to confirm that it is correct. Complete a single intraperitoneal injection;

[0038...

Embodiment 2

[0042] The modeling effect comparison of the busulfan of embodiment 2 different doses

[0043]The modeling method of Example 1 was used to prepare model mice, the difference being the dose of busulfan, and the modeling effects of three different doses of 20mg / kg, 30mg / kg, and 40mg / kg were compared. The result is as figure 1 shown by figure 1 It can be seen that on the 36th day, in the seminiferous tubules of the mouse testis treated by two doses of 20mg / kg and 30mg / kg, germ cells can still be seen, while in the seminiferous tubules of the mice treated by the dose of 40mg / kg, only the same There were no spermatogenic cells in the basal part of the Sertoli cells, therefore, 40mg / kg dose of busulfan is suitable as a modeling dose.

Embodiment 3

[0044] Example 3 Effects of time on the seminiferous tubules and testis of model mice

[0045] Model mice were prepared using the modeling method in Example 1, the difference being that the time after busulfan injection was different, and the changes in the testes of the mice were compared after 0 day, 9 days, 18 days, 27 days, and 36 days. The result is as figure 2 shown by figure 2 It can be seen that from the 9th day to the 18th day, the seminiferous tubules and the testis / body weight coefficient changed drastically, suggesting that the model may be in a reversible stage before the 18th day, and gradually turn into an irreversible state after the 18th day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention a method for constructing an azoospermia mouse model, comprising the following steps: (1) providing sexually mature male mice weighing 25-35g; (2) dissolving busulfan in DMSO and diluting with normal saline to obtain a diluent; and (3) sterilizing the mouse abdomen with alcohol and drying, absorbing the diluent obtained in step (2) and inserting the needle, and completing the first intraperitoneal injection after withdrawal and confirmation; repeating the injection for three times at intervals in the same day and then obtaining the azoospermia mouse model after 35 to 37 days. Themethod provided by the invention has high success rate of modeling and good stability. According to the invention, modeling of 84 C57BL / 6 mice with azoospermia has been cumulatively completed. Totalnumber of models is 84 / 84 by testicular HE staining identification, and the success rate of modeling is 100%. By the adoption of the method for constructing the model, the death rate of mice is 0%; and according to the method, among 84 cumulatively-injected C57BL / 6 mice, the death toll is 0, and the death rate is 0%.

Description

technical field [0001] The invention relates to the technical field of animal model construction, in particular to a method for constructing an azoospermia mouse model. Background technique [0002] According to whether the vas deferens is unobstructed, azoospermia can be divided into obstructive azoospermia and non-obstructive azoospermia. Non-obstructive azoospermia is mainly caused by testicular spermatogenesis dysfunction, and clinical treatment is difficult. Currently, there is no effective drug treatment for this part of patients, and surgical sperm retrieval is mainly relied on, such as testicular biopsy, open biopsy or microscopic sperm retrieval. Operation. In recent years, more and more methods have been reported for the treatment of non-obstructive azoospermia, such as spermatogonial stem cell transplantation. With the development of cell replacement therapy for non-obstructive azoospermia, it is necessary to obtain a stable animal model of azoospermia for exper...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/255
CPCA61K9/0019A61K31/255
Inventor 刘贵华邓春华谢云邓存灿杨其运张弛吕林艳姚嘉慧
Owner THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com